Eris Lifesciences has kicked off the financial year on a high note, reporting an impressive 41.7% year-on-year rise in net profit for the first quarter. The company posted a profit of ₹118 crore, compared to ₹83.3 crore during the same period last year, signaling strong operational momentum and strategic execution.
The topline also saw a healthy increase, with revenue climbing 7.4% to ₹773 crore, up from ₹720 crore in Q1 of the previous fiscal. While the revenue growth was modest, the company’s focus on efficiency clearly paid off, as reflected in its operating performance.
EBITDA for the quarter rose to ₹277 crore, a 10.8% increase from ₹250 crore a year ago. The EBITDA margin improved as well, reaching 35.8% compared to 34.71% in the previous year—showing that Eris not only grew its earnings but also managed to expand profitability.
